Recent enforcement activity across the healthcare industry underscores continued scrutiny around billing practices, particularly involving telemedicine, durable medical equipment (DME), and medical necessity. Here’s a high-level look at 10 notable cases reported since early March, ranked by scale and impact:
1. $59.9M Medicare DME Fraud Scheme (Texas)
A Texas individual received a lengthy prison sentence for involvement in a massive scheme billing Medicare for medically unnecessary equipment—one of the largest cases in this group.
2. $12.5M Fraud and Tax Evasion Case (Alaska)
An Anchorage physician was sentenced to over six years in prison for a large-scale fraud operation, along with millions in unpaid taxes.
3. $11M Medical Center Fraud (California)
A California facility was shut down and its owner charged in a significant fraud scheme, signaling serious operational and compliance failures.
4. $6.9M False Claims Settlement (Kinex Medical Company)
Medical equipment provider Kinex Medical Company agreed to a multimillion-dollar settlement tied to false claims submitted to federal programs.
5. $4M Settlement for Unnecessary Procedures (Maryland)
A vascular company and its physician CEO resolved allegations of billing for medically unnecessary services.
6. Telemedicine & Genetic Testing Fraud (Alabama – $2.7M)
An Alabama physician was sentenced for a scheme involving unnecessary DME and genetic testing—highlighting ongoing risks in telehealth-related billing.
7. False Statements in Fraud Scheme (Florida)
A Florida physician pleaded guilty in a case centered on improper billing tied to genetic testing and DME.
8. $90-Month Sentence in DME Scheme (Texas)
Another major DME-related case resulted in a lengthy prison term for fraudulent Medicare billing practices.
9. Orthotic Brace Telemarketing Scheme (Kansas)
An anesthesiologist was sentenced for billing Medicare for unnecessary orthotic devices tied to telemarketing efforts.
10. Ongoing FCA Litigation (Missouri & Tennessee)
Physicians in Missouri and Erlanger Health System in Tennessee are facing or continuing to defend against False Claims Act allegations related to billing practices and medical device usage.
Why It Matters
These cases reinforce a clear trend: federal enforcement remains highly focused on medical necessity, documentation, and billing accuracy—especially in high-risk areas like DME, telemedicine, and genetic testing. For providers, proactive compliance, internal audits, and proper documentation remain critical to avoiding similar exposure.